Knowledge center

The place to find all the most innovative research and information on novel biologics and biosimilars.


Konstantin Matentzoglu for Puls Biznesu

We are expanding our research portfolio - that's what you'll read about in Puls Biznesu. Editor Marcel Zatoński spoke with a member of our supervisory board, Dr. Konstantin Matentzoglu, among other topics, about the completion of the first stage of clinical trials for PB0016, our proposed biosimilar medicine to Entyvio®* (vedolizumab), reference drug developed by Takeda.


You can find all the latest presentations, brochures and fact sheets below covering our solutions and portfolio.

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.